RRAS and RRAS2 mutations are oncogenic drivers in lung cancer and are sensitive to the PAN-RAS inhibitor RMC-6236 Meeting Abstract
| Authors: | Pfeil, A. J.; Zhang, T.; Febres-Aldana, C. A.; Cheng, R.; Mattar, M. S.; Arbour, K.; Ladanyi, M.; Yang, S. R.; Somwar, R. |
| Abstract Title: | RRAS and RRAS2 mutations are oncogenic drivers in lung cancer and are sensitive to the PAN-RAS inhibitor RMC-6236 |
| Meeting Title: | 2024 World Conference on Lung Cancer |
| Keywords: | lung adenocarcinoma; targeted therapy |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 19 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2024 Sep 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S313 |
| Language: | English |
| ACCESSION: | WOS:001337925602064 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2024.09.560 |
| Notes: | Meeting Abstract: P3.03I.10 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
